Searched for
GENERIC DRUG SAVINGS
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
Why the ET Most Innovative AI Product Awards 2026 are spotlighting industry-specific innovationThe most impactful AI products of 2026 aren't built to do everything; they're built to solve one problem exceptionally well. The ET Most In...
The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
US drugs site TrumpRx to list 600 generics as Donald Trump targets lower pricesPresident Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs...
Paracetamol may get costlier as Vizag chemists warn 30–40% drug cost surge amid Iran war-led pharma cost shockThe ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...
Just the booster pill Indian pharma needsIndian Pharma must look at strengthening its presence in established markets in Latin America, China, Russia, Africa and East Europe. This ...
UP doctors told to prescribe only generic medicinesThe government doctors in Uttar Pradesh have been told to prescribe only generic drugs to patients as per the new guidelines issued by the ...
US Medicare could have saved $1 billion by substituting branded drugs, says studyThe revelation is significant for India since Indian pharma companies supply 40 per cent of generic drugs consumed in the US.
People saving up to 90% on medicines, surgicals under PMBJP: Government"Generally generic medicines are less expensive. Medicines, surgicals and consumables under the PMBJP are providing 50-90 per cent savings ...
Indices crash, but healthcare stocks rise on new optimismTo add to their woes, market analysts had predicted a win for Hillary Clinton, who had kicked off a firestorm by threatening to clamp down ...
Taro drug pricing probe may widen to other generic drug makersResearch by IIFL shows several generic drug companies, including a few top Indian generic drug makers, effected steep price increases withi...
No quality control for life-saving generic drugs, government apatheticA case in point is a life-saving drug, Liposomal Amphotericin B, which is used to treat fungal infections in critically-ill patients.
Fight medical apartheid: While Indian pharma keeps drugs affordable, western MNCs can be blatantly discriminatoryIf drugs are developed only for those who can afford them, but not for those who need them, isn't it unethical?
ACTA will make life saving drugs costlier for the poorProvisions of ACTA stretch its ambit to civil trademark infringement, which has no relation to a product being counterfeit.
- Indian pharma players to benefit from generic drugs in US
Increased use of generic drugs helped the US healthcare system save billions of dollars over last decade. 6 mysteries about swine flu | Swi...
- Generic generics may escape proposed trade margins cap
The government’s proposed restriction on drug trade margins is likely to exclude products of four industry titans--GlaxoSmithKline, Ranbaxy...